
Casper
4.2K posts












Beyond the Breach: Taming the Hantavirus Threat with Favipiravir A new horizon in antiviral defense: how oral favipiravir should be trialed in and offers hope for victims of the MV Hondius debacle detained in biosecurity centers and in self-quarantine. "efficacy of T-705 [favipiravir] depends on the time of administration; however, based on the excellent safety record of this agent in animals and humans, T-705 represents an improved candidate compound for utilization in monotherapy against suspected exposures (i.e., laboratory incidents, close contacts with HPS [hantavirus pulmonary syndrome] cases, or rodent bites), as well as for combination therapeutic approaches in a clinical setting." Why is University of Nebraska and Emory not mentioning this drug during their media interviews? @unmc @EmoryMedicine @McCulloughFund open.substack.com/pub/petermccul…



This evil demon truly deserves to burn in hell.











